Characteristics of patients achieving complete or partial response (CR/PR) with tazemetostat (TAZ) in wild‐type relapsed/refractory (R/R) follicular lymphoma (FL) Meeting Abstract


Authors: Batlevi, C. L.; Salles, G.; Tilly, H.; Chaidos, A.; McKay, P.; Phillips, T.; Assouline, S.; Campbell, P.; Ribrag, V.; Laurent Damaj, G.; Dickinson, M.; Jurczak, W.; Kaźmierczak, M.; Opat, S.; Radford, J. R.; Schmitt, A.; Rajarethinam, A.; Shang, G.; Morschhauser, F.
Abstract Title: Characteristics of patients achieving complete or partial response (CR/PR) with tazemetostat (TAZ) in wild‐type relapsed/refractory (R/R) follicular lymphoma (FL)
Meeting Title: 16th International Conference on Malignant Lymphoma - Virtual Edition
Journal Title: Hematological Oncology
Volume: 39
Issue: Suppl. 2
Meeting Dates: 2021 Jun 18-22
Meeting Location: Virtual
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2021-06-01
Start Page: 167
End Page: 169
Language: English
ACCESSION: 150946621
DOI: 10.1002/hon.21_2880
PROVIDER: EBSCOhost
PROVIDER: cinahl
PUBMED: 34105791
DOI/URL:
Notes: Meeting Abstract: 109 -- Accession Number: 150946621 -- Entry Date: In Process -- Revision Date: 20210618 -- Publication Type: Article -- Supplement Title: Jun2021 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Connie Wing-Ching Lee Batlevi
    176 Batlevi